4.99
3.31%
0.16
Handel nachbörslich:
4.88
-0.11
-2.20%
Finanzdaten der Eledon Pharmaceuticals Inc-Aktie (ELDN)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
-
|
- | - | - | - |
Operating Expenses
|
5.14%
10.87
|
10.34 | 11.20 | 10.35 | 11.11 |
Operating Income/Loss |
5.14%
-10.87
|
-10.34 | -11.20 | -10.35 | -11.11 |
Income/Loss From Continuing Operations Before Tax |
6.95%
-10.29
|
-9.626 | -10.35 | -9.579 | -10.77 |
Income/Loss From Continuing Operations After Tax |
6.95%
-10.29
|
-9.626 | -10.35 | -9.579 | -10.77 |
Net Income/Loss
|
6.95%
-10.29
|
-9.626 | -10.35 | -9.579 | -10.77 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
1,560%
29.99
|
1.8061 | 29.97 | 24.01 | 14.29 |
Diluted Average Shares |
1,560%
29.99
|
1.8061 | 29.97 | 24.01 | 14.29 |
Basic Earnings Per Share |
17.24%
-0.34
|
-0.29 | -0.35 | -0.40 | -0.75 |
Diluted Earnings Per Share |
17.24%
-0.34
|
-0.29 | -0.35 | -0.40 | -0.75 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):